Schizophrenia News and Research

Latest Schizophrenia News and Research

Mount Sinai receives Le Foundation gift for psychiatric neuroimaging study

The Department of Psychiatry at Mount Sinai School of Medicine has received a $250,000 gift from The Iris & Junming Le Foundation to advance neuroimaging research conducted by young scientists in the early stages of their careers.

23 Feb 2012

Hoarders are mentally ill and need help

According to experts people who are compulsive hoarders are ill with a serious mental disorder and need help. Hoarding is affecting between 400,000 and 1.1 million Australians, a conference in Sydney heard this week, and can affect more than just elderly people living alone. Yet it is only now gaining acceptance as a clinical condition with its inclusion this year in the Diagnostic and Statistical Manual of Mental Disorders.

22 Feb 2012

BioLineRx BL-7010 may reduce gluten toxicity in patients with celiac disease

BioLineRx, a biopharmaceutical development company, announced the publication of pre-clinical results demonstrating that BL-7010, an orally available treatment for celiac disease, reduces gluten toxicity (the negative effect of gluten on the patient's body).

22 Feb 2012

Alexza prices underwritten public offering of 44,000,000 shares of common stock and warrants

Alexza Pharmaceuticals, Inc., or the Company, today announced that it has priced its previously announced underwritten public offering of 44,000,000 shares of common stock and warrants to purchase 44,000,000 shares of common stock.

17 Feb 2012

State roundup: Settlements for mental health facilities lawsuits; Minn., Oregon insurers face scrutiny

But the survey underway in Prince George's County is intended to address a complex problem. Officials expect the data to give them a detailed look at the state of health and health care in the county, where conditions such as diabetes and heart disease are much more common than in the rest of the region and most of the state.

17 Feb 2012

New genetic resource to accelerate development of novel treatments for diseases

A new genetic resource from an international research consortium is expected to accelerate the development of new cures and treatments for a wide range of human diseases. This project, called the mouse "Collaborative Cross" (CC) resource, will increase the likelihood that experiments conducted in mice will advance our understanding of human biology.

17 Feb 2012

Wikipedia the most highly rated mental health source

University of Melbourne researchers have found Wikipedia is the most highly rated website for accessing information on mental-health related topics.

16 Feb 2012

New WSU model system focuses on causes of everyday MS symptoms

Annoying, frustrating symptoms like difficulty hearing or remembering things can complicate everyday living for multiple sclerosis (MS) patients, but most research to date has focused on the disease's less frequent but more debilitating consequences.

15 Feb 2012

State roundup: Health law implementation in Alaska, Calif., mental health funding challenges, Miami's heart attack network

Alaska is one of several states suing to overturn the Affordable Care Act -- President Obama's health care overhaul. But behind the scenes, state agencies are quietly working on implementing various requirements in the law. One of those requirements is an exchange, which will work kind of like Expedia, but for health insurance plans. While the state studies its options, a bill moving through the legislature would also establish an exchange.

13 Feb 2012

New smartphone can help people with mental health problems

Brooding in your apartment on Saturday afternoon? A new smart phone intuits when you're depressed and will nudge you to call or go out with friends. It's the future of therapy at a new Northwestern University Feinberg School of Medicine center where scientists are inventing web-based, mobile and virtual technologies to treat depression and other mood disorders. The phone and similar projects bypass traditional weekly therapy sessions for novel approaches that provide immediate support and access to a much larger population.

8 Feb 2012

Study to understand how brain processes information in competitive settings

Researchers have found a way to study how our brains assess the behavior - and likely future actions - of others during competitive social interactions. Their study, described in a paper in the Proceedings of the National Academy of Sciences, is the first to use a computational approach to tease out differing patterns of brain activity during these interactions, the researchers report.

7 Feb 2012

Neuralstem announces registered direct placement of 5,200,000 shares of common stock

Neuralstem, Inc. announced today that it has entered into agreements with certain institutional and accredited investors for a registered direct placement of 5,200,000 shares of common stock at a price of $1.00 per share for aggregate gross proceeds of $5,200,000.

6 Feb 2012

BioLineRx, Genoscience and RFS Pharma enter agreement for BL-8030 Hepatitis C treatment

BioLineRx, a biopharmaceutical development company, announced today it has signed a worldwide, exclusive license agreement with Genoscience and RFS Pharma to develop and commercialize BL-8030, an orally available treatment for Hepatitis C.

6 Feb 2012

Electronic app may help schizophrenia patients to avoid hallucinations

When a patient afflicted with schizophrenia hears inner voices something is taking place inside the brain that prevents the individual from perceiving real voices. A simple electronic application may help the patient learn to shift focus.

3 Feb 2012

Mental illness suspect genes are among the most environmentally responsive regulatory mechanisms

For the first time, scientists have tracked the activity, across the lifespan, of an environmentally responsive regulatory mechanism that turns genes on and off in the brain's executive hub.

3 Feb 2012

Researchers reveal how antipsychotics affect metabolism by SMAD3 activation

In a paper published January 31 in the journal Molecular Psychiatry, researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham) reveal how antipsychotic drugs interfere with normal metabolism by activating a protein called SMAD3, an important part of the transforming growth factor beta (TGFbeta) pathway.

2 Feb 2012

Study finds no link between BDV and psychiatric illness

Over the past 30 years, numerous studies have linked Borna disease virus (BDV) with mental illnesses such as bipolar disorder, schizophrenia, anxiety disorder and dementia. Genetic fragments and antibodies to this RNA virus, which causes behavior disorders in a range of mammals and birds, have been found to be prevalent in psychiatric patients, but study results have been inconsistent. Now, the first blinded, case-control study to examine this issue finds no association between the virus and psychiatric illness.

1 Feb 2012

States redesigning mental health programs, coverage and care

States are grappling with mental health issues including a redesign of a program in Iowa, increased coverage for the mentally ill in California and a mental health first aid pilot program in Pennsylvania.

30 Jan 2012

Genetic variation predisposes children to complications linked with second-generation anti-psychotics

Researchers have found a genetic variation predisposing children to six-times greater risk of developing metabolic syndrome when taking second-generation anti-psychotic medications. Metabolic syndrome is a cluster of conditions that are risk factors for cardiovascular disease.

25 Jan 2012

Changes in endocannabinoid system may have important implications for psychiatric disorders

Changes in the endocannabinoid system may have important implications for psychiatric and addiction disorders. This brain system is responsible for making substances that have effects on brain function which resemble those of cannabis products, e.g., marijuana.

25 Jan 2012

Schizophrenia News and Research

Latest Schizophrenia News and Research

Mount Sinai receives Le Foundation gift for psychiatric neuroimaging study

Hoarders are mentally ill and need help

BioLineRx BL-7010 may reduce gluten toxicity in patients with celiac disease

Alexza prices underwritten public offering of 44,000,000 shares of common stock and warrants

State roundup: Settlements for mental health facilities lawsuits; Minn., Oregon insurers face scrutiny

New genetic resource to accelerate development of novel treatments for diseases

Wikipedia the most highly rated mental health source

New WSU model system focuses on causes of everyday MS symptoms

State roundup: Health law implementation in Alaska, Calif., mental health funding challenges, Miami's heart attack network

New smartphone can help people with mental health problems

Study to understand how brain processes information in competitive settings

Neuralstem announces registered direct placement of 5,200,000 shares of common stock

BioLineRx, Genoscience and RFS Pharma enter agreement for BL-8030 Hepatitis C treatment

Electronic app may help schizophrenia patients to avoid hallucinations

Mental illness suspect genes are among the most environmentally responsive regulatory mechanisms

Researchers reveal how antipsychotics affect metabolism by SMAD3 activation

Study finds no link between BDV and psychiatric illness

States redesigning mental health programs, coverage and care

Genetic variation predisposes children to complications linked with second-generation anti-psychotics

Changes in endocannabinoid system may have important implications for psychiatric disorders

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Schizophrenia News and Research

Latest Schizophrenia News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in